熱門資訊> 正文

Cellectar Biosciences非GAAP每股收益为-1.33美元

2026-05-14 19:18

Cellectar Biosciences(CLRB) 0

Cellectar Biosciences press release (CLRB): Q1 Non-GAAP EPS of -$1.33.
As of March 31, 2026, the company had cash and cash equivalents of $8.3 million, compared to $13.2 million as of December 31, 2025, which does not reflect net proceeds of approximately $31 million from the May 2026 offering

More on Cellectar Biosciences

Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call Transcript
Seeking Alpha’s Quant Rating on Cellectar Biosciences
Historical earnings data for Cellectar Biosciences
Financial information for Cellectar Biosciences

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。